New data show efficacy and safety of Pradaxa® in the management of VTE in children

[In The News]

RIDGEFIELD, Conn., July 8, 2019 /PRNewswire/ -- Boehringer Ingelheim today announced results from two pediatric studies of Pradaxa®, which were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia. The Phase IIb/III DIVERSITY...

View the full article